After-Hours Stock Movers 02/10: (MVIS) (DMTK) (RNWK) Higher; (FLDM) (ELY) (KDMN) Lower (more...)

Today's After-Hours Stock Movers:

MicroVision, Inc. (NASDAQ: MVIS) 38.5% HIGHER; announced that it has received necessary components and equipment to meet its April milestone of completing A-Samples of its Long Range Lidar Sensor. The Company also announced that it has started outdoor testing of key performance features on its development platform.

DermTech, Inc. (NASDAQ: DMTK) 22.7% HIGHER; has contracted, effective 2/1/2021, with Blue Cross Blue Shield of Texas (“BCBSTX”) to make DermTech’s Pigmented Lesion Assay (“PLA”) available to its approximately 6 million members in the State of Texas.

RealNetworks (NASDAQ: RNWK) 18.6% HIGHER; reported Q4 EPS of $0.16, versus ($0.08) reported last year. Revenue for the quarter came in at $17.6 million, versus $16.6 million reported last year.

Sundial Growers (NASDAQ: SNDL) 16.6% HIGHER; adds to Wednesday's intra-day gains of 79%.

Fluidigm (NASDAQ: FLDM) 16.3% LOWER; reported Q4 EPS of ($0.13), $0.06 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $44 million versus the consensus estimate of $50.72 million.

Sonos (NASDAQ: SONO) 16% HIGHER; reported Q1 EPS of $1.17, $0.29 better than the analyst estimate of $0.88. Revenue for the quarter came in at $645.6 million versus the consensus estimate of $589.86 million. Sonos sees FY2021 revenue of $1.525-1.575 billion, versus the consensus of $1.46 billion.

Tilray, Inc. (NASDAQ: TLRY) 14.8% HIGHER; adds to intra-day gains of 51%

Callaway Golf (NYSE: ELY) 13% LOWER; reported Q4 EPS of ($0.33), $0.14 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $375 million versus the consensus estimate of $337.44 million.

illow (NASDAQ: Z) (NASDAQ: ZG) 11.8% HIGHER; reported Q4 revenue of $789 million versus the consensus estimate of $740.24 million. Entered into a definitive agreement to acquire ShowingTime.com, Inc., an online scheduling platform for home showings, for $500 million.

Kadmon Holdings, Inc. (NASDAQ: KDMN) 9.5% LOWER; today announced its intent to offer, subject to market conditions and other factors, $150 million aggregate principal amount of convertible senior notes due 2027 (the "Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Kadmon also expects to grant the initial purchaser of the Notes a 13-day option to purchase up to an additional $30 million aggregate principal amount of the Notes, solely to cover over-allotments.

iRobot Corp. (NASDAQ: IRBT) 8.6% HIGHER; reported Q4 EPS of $0.84, $0.53 better than the analyst estimate of $0.31. Revenue for the quarter came in at $544.8 million versus the consensus estimate of $494.07 million. iRobot Corp. sees FY2021 EPS of $3.00-$3.25, versus the consensus of $2.19. iRobot Corp. sees FY2021 revenue of $1.635-1.675 billion, versus the consensus of $1.47 billion.

Onconova Therapeutics, Inc. (NASDAQ: ONTX) 6% LOWER; announced that it intends to offer and sell shares of its common stock in an underwritten public offering. All of the shares to be sold in the offering will be offered by Onconova. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. In addition, Onconova intends to grant the underwriters a thirty-day option to purchase up to an additional 15 percent of shares of its common stock offered in the public offering.

Zynga (NASDAQ: ZNGA) 4.6% HIGHER; reported Q4 EPS of ($0.05), $0.14 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $616 million versus the consensus estimate of $677.73 million.

TherapeuticsMD, Inc. (NASDAQ: TXMD) 4.2% LOWER; announced an underwritten public offering of its common stock. The Company has granted the underwriter a 30-day option to purchase up to an additional 15% of the number of shares of its common stock offered in the offering. All of the shares in the offering are to be sold by TherapeuticsMD.